logologo
QuantliQuantli

TG Therapeutics Inc

TGTX

NASDAQ

Biotechnology

$48.74

USD

+0.80 (+1.67%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $7.34B

Volume 1.1M

Price Target

$77.00$77.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $77.00 and a min estimate of $77.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$77.00

+$7.0 vs prior

Implied Upside

+58.0%

+14.4% vs prior

Analyst Covering

1

Unchanged vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

50%

A mix of recent and older ratings shape this consensus

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Emily Bodnar

HC Wainwright & Co.

Buy

Maintained

4 weeks ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

TWST

Twist Bioscience Corp

$118.57

-5.4%

RYTM

Rhythm Pharmaceuticals Inc

$115.48

-0.5%

IBRX

Immunitybio Inc

$7.57

-1.1%

CGON

CG Oncology Inc

$75.03

+0.4%

COGT

Cogent Biosciences Inc

$37.93

+1.7%

ORKA

Oruka Therapeutics Inc

$111.04

+2.7%